Pure Global
NCT06277141

The Vitality Mammography Messaging Study

The Vitality Mammography Study - Testing the Effectiveness of a Booking Platform on Receipt of Screening Mammography - a Randomized Controlled Trial.
Wits Health Consortium (Pty) Ltd·ClinicalTrials.gov·behavioralRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Breast Cancer Female
Drug/Device/Intervention
Standard message
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Wits Health Consortium (Pty) Ltd
Location
Johannesburg, South Africa
Timeline & enrollment
Phase
N/A
Start date
Sep 27, 2023
End date
Mar 31, 2024
Enrollment
6665 participants
Primary outcome

Comparison of mammography screening rates using WhatsApp

Summary

The investigators will be conducting a randomized controlled trial amongst members of a
 Wellness Program to test receipt of mammogram using the Whatsapp social media platform and
 testing various messages.

ICD-10 classifications
Malignant neoplasm: Breast, unspecifiedMalignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedPersonal history of malignant neoplasm of breast
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06277141
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06277141 through Pure Global AI's free database. This phase not specified trial is sponsored by Wits Health Consortium (Pty) Ltd and is currently Recruitment Completed. The study focuses on Breast Cancer Female. Target enrollment is 6665 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.